Your Messages Inbox
Your Article Summary
See Latest ArticlesCryoLife Announces First Clinical Use of BioFoam
Cryolife, 09/11/09
CryoLife, Inc., (NYSE: CRY) an implantable biological medical device and cardiovascular tissue processing company, announced the first clinical implant of its BioFoam(R) Surgical Matrix, which received CE mark approval in 2009. BioFoam was used in a liver resection procedure following tumor removal as a supplemental measure to promote hemostasis by sealing vessels.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Huntington Hill Installs Toshiba Aquilion Premium CT
Imaging Economics, 11/25/09
Baytubes carbon nanotubes in marine coatings help reduce frictional resistance
BayNews International, 11/24/09
Article Search
Sponsor